Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
Innovations in biomarker detection and personalized medicine for prostate cancer
News-Medical.Net August 23, 2024
In a recent comprehensive review published in Cyborg Bionic Systems, researchers led by Keyi Li from the General Hospital of Northern Theater Command in Shenyang, along with international collaborators, detail significant advances in the identification and application of biomarkers for prostate cancer (PCa). This critical insight is pivotal as prostate cancer remains one of the most common malignancies among men globally, emphasizing the urgent need for effective diagnostic and therapeutic strategies.
Prostate cancer is characterized by a multitude of molecular aberrations that complicate its early detection and treatment. The review discusses various biomarkers across molecular, cellular, and exosomal categories, showcasing their potential to revolutionize how prostate cancer is diagnosed and treated.
One of the major highlights of the review is...
Today's Sponsors
Today's Sponsor